Background & Aims: The nonmedical costs of colorectal cancer screening are unknown.
However, they might influence screening uptake and impact the cost-effectiveness of …

Background & Aims: Screening rates for colorectal cancer remain low compared with
screening rates for other cancers. The size of the unscreened population and the capacity to …

Objectives: Clinical trials have demonstrated that fecal occult blood screening for colorectal
cancer can significantly reduce mortality. However, to be deemed a priority from a public …

OBJECTIVES: Primary care physicians and internal medicine residents have poor
understanding of colorectal cancer screening and the use of fecal occult blood tests. If …

OBJECTIVE: Cancer Care Ontario has recommended a population‐based colorectal cancer
(CRC) screening program using fecal occult blood testing. Patients who test positive should …

OBJECTIVES: Fecal occult blood testing has been shown to reduce mortality from colorectal
cancer in large randomized, controlled trials conducted in the United States, Denmark, and …

Background Colorectal cancer screening is widely recommended, but often under-utilized.
In addition, significant demographic differences in screening utilization exist. Insurance …

Physicians respond to a positive fecal occult blood test with a variety of workup strategies.
To study the effect of the choice of strategy on the net costs and health benefits of colorectal …

OBJECTIVES Inclusion of colorectal cancer screening as a performance measure in the
Veterans Health Administration (VHA) health system appears to have improved screening …

Objectives: To estimate the cost-effectiveness of faecal occult blood (FOB) screening for
colorectal cancer within the Nottingham trial. Setting: A randomised controlled trial (1981 …